12/5
06:30 am
hims
Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Low
Report
Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
12/5
05:43 am
hims
Hims & Hers Continues Major International Expansion With Official Entry Into Canada [Yahoo! Finance]
Low
Report
Hims & Hers Continues Major International Expansion With Official Entry Into Canada [Yahoo! Finance]
12/5
05:02 am
hims
A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity [Seeking Alpha]
Low
Report
A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity [Seeking Alpha]
12/4
05:06 pm
hims
Humana And Mark Cuban's Cost Plus Drugs Working On Partnership To Lower Prices [Forbes]
Low
Report
Humana And Mark Cuban's Cost Plus Drugs Working On Partnership To Lower Prices [Forbes]
12/4
11:34 am
hims
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory [Yahoo! Finance]
Low
Report
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory [Yahoo! Finance]
12/4
10:46 am
hims
The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz [Yahoo! Finance]
Low
Report
The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz [Yahoo! Finance]
12/4
08:01 am
hims
Hims & Hers Health signs agreement to acquire YourBio Health [Yahoo! Finance]
Medium
Report
Hims & Hers Health signs agreement to acquire YourBio Health [Yahoo! Finance]
12/4
07:00 am
hims
Hims & Hers Now Serving Customers in Canada
Medium
Report
Hims & Hers Now Serving Customers in Canada
12/4
07:00 am
hims
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
Medium
Report
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
12/3
09:00 am
hims
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
Low
Report
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
12/2
07:07 pm
hims
Hims & Hers Health (HIMS): Evaluating Valuation After Recent Share Price Drop [Yahoo! Finance]
Low
Report
Hims & Hers Health (HIMS): Evaluating Valuation After Recent Share Price Drop [Yahoo! Finance]
11/17
08:00 am
hims
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization
Medium
Report
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization
11/17
06:00 am
hims
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy
Medium
Report
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy
11/16
09:36 pm
hims
Hims & Hers Health's Valuation in Focus After Wrongful Death Lawsuit Raises New Questions [Yahoo! Finance]
Medium
Report
Hims & Hers Health's Valuation in Focus After Wrongful Death Lawsuit Raises New Questions [Yahoo! Finance]
11/14
11:16 am
hims
Family Alleges Hims & Hers Health, Inc.'s Rush Into Mental Healthcare Violated Washington Law and Resulted in Son's Death [Yahoo! Finance]
Low
Report
Family Alleges Hims & Hers Health, Inc.'s Rush Into Mental Healthcare Violated Washington Law and Resulted in Son's Death [Yahoo! Finance]
11/13
12:11 pm
hims
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys [Yahoo! Finance]
Low
Report
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys [Yahoo! Finance]
11/13
12:00 pm
hims
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
Low
Report
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
11/10
04:18 am
hims
Hims & Hers Health's Q3 Earnings Call: Our Top 5 Analyst Questions [Yahoo! Finance]
Medium
Report
Hims & Hers Health's Q3 Earnings Call: Our Top 5 Analyst Questions [Yahoo! Finance]
11/9
05:03 am
hims
Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? [Yahoo! Finance]
Low
Report
Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock? [Yahoo! Finance]
11/5
07:03 am
hims
Hims & Hers: GLP-1 Partnership Could Unlock Value [Seeking Alpha]
Low
Report
Hims & Hers: GLP-1 Partnership Could Unlock Value [Seeking Alpha]
11/5
01:33 am
hims
Hims & Hers Health (HIMS) Margin Compression Challenges Bullish Narratives Despite Sustained Profit Growth [Yahoo! Finance]
Low
Report
Hims & Hers Health (HIMS) Margin Compression Challenges Bullish Narratives Despite Sustained Profit Growth [Yahoo! Finance]
11/4
10:38 pm
hims
Tandem Diabetes Earnings: What To Look For From TNDM [Yahoo! Finance]
Medium
Report
Tandem Diabetes Earnings: What To Look For From TNDM [Yahoo! Finance]
11/4
11:31 am
hims
HIMS Q3 Deep Dive: Personalized Offerings and Strategic Expansion Shape Telehealth Growth [Yahoo! Finance]
Medium
Report
HIMS Q3 Deep Dive: Personalized Offerings and Strategic Expansion Shape Telehealth Growth [Yahoo! Finance]
11/4
08:43 am
hims
Hims & Hers Health (NYSE:HIMS) was given a new $32.00 price target on by analysts at UBS Group AG.
Medium
Report
Hims & Hers Health (NYSE:HIMS) was given a new $32.00 price target on by analysts at UBS Group AG.
11/4
08:09 am
hims
Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Medium
Report
Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.